Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salim Chahin

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Neurovirology|November 19, 2014
A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathySalim Chahin, Joseph R Berger
Current Neurology and Neuroscience Reports|February 29, 2016
Vaccines in Multiple SclerosisEric M L Williamson, Salim Chahin, Joseph R Berger
International Journal of MS Care|January 12, 2024
Direct and Indirect Care of Patients With Multiple Sclerosis: Burden on Providers and Impact of Portal MessagesRola Mahmoud, Katie Callahan, Doug Schell, et al.
Multiple Sclerosis and Related Disorders|June 3, 2023
Obesity, gut microbiota, and multiple sclerosis: Unraveling the connectionAmjad Samara, Claudia Cantoni, Laura Piccio, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|November 6, 2014
Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of lifeSalim Chahin, Laura J Balcer, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 13, 2020
Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteriaAndrew J Solomon, Roman Pettigrew, Robert T Naismith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2017
Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte countErin E Longbrake, Claudia Cantoni, Salim Chahin, et al.
Multiple Sclerosis and Related Disorders|December 23, 2019
Clinical instrument to retrospectively capture levels of EDSSJohn Robert Ciotti, Noah Sanders, Amber Salter, et al.
Neurology. Clinical Practice|September 19, 2025
Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple SclerosisPengxiang Li, John K Lin, Matthew J Klebanoff, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2020
Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple SclerosisPengxiang Li, Vrushabh P Ladage, Joseph Berger, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Neurovirology|November 19, 2014
A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathySalim Chahin, Joseph R Berger
Current Neurology and Neuroscience Reports|February 29, 2016
Vaccines in Multiple SclerosisEric M L Williamson, Salim Chahin, Joseph R Berger
International Journal of MS Care|January 12, 2024
Direct and Indirect Care of Patients With Multiple Sclerosis: Burden on Providers and Impact of Portal MessagesRola Mahmoud, Katie Callahan, Doug Schell, et al.
Multiple Sclerosis and Related Disorders|June 3, 2023
Obesity, gut microbiota, and multiple sclerosis: Unraveling the connectionAmjad Samara, Claudia Cantoni, Laura Piccio, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|November 6, 2014
Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of lifeSalim Chahin, Laura J Balcer, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 13, 2020
Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteriaAndrew J Solomon, Roman Pettigrew, Robert T Naismith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2017
Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte countErin E Longbrake, Claudia Cantoni, Salim Chahin, et al.
Multiple Sclerosis and Related Disorders|December 23, 2019
Clinical instrument to retrospectively capture levels of EDSSJohn Robert Ciotti, Noah Sanders, Amber Salter, et al.
Neurology. Clinical Practice|September 19, 2025
Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple SclerosisPengxiang Li, John K Lin, Matthew J Klebanoff, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2020
Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple SclerosisPengxiang Li, Vrushabh P Ladage, Joseph Berger, et al.
Pageof 3